Sidechain-linked inhibitors of HIV-1 protease dimerization

Differential modification of acyl groups and sidechain functionality within uniquely crosslinked dimerization inhibitors of HIV-1 protease provided diverse structures with the most potent inhibitory constants in the low nM range.